SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,984,976 | +4.7% | 5,082,000 | 0.0% | 0.04% | -4.8% |
| Q2 2023 | $8,580,143 | -37.4% | 5,082,000 | -28.2% | 0.04% | -39.1% |
| Q1 2023 | $13,695,632 | -24.7% | 7,080,000 | -51.2% | 0.07% | -22.5% |
| Q2 2022 | $18,198,000 | -4.5% | 14,500,000 | 0.0% | 0.09% | +71.2% |
| Q1 2022 | $19,049,000 | – | 14,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |